POLYMORPHIC FORMATION OF MORPHINE FROM CODEINE IN POOR AND EXTENSIVE METABOLIZERS OF DEXTROMETHORPHAN - RELATIONSHIP TO THE PRESENCE OF IMMUNOIDENTIFIED CYTOCHROME-P-450IID1

被引:83
作者
MORTIMER, O [1 ]
PERSSON, K [1 ]
LADONA, MG [1 ]
SPALDING, D [1 ]
ZANGER, UM [1 ]
MEYER, UA [1 ]
RANE, A [1 ]
机构
[1] UNIV BASEL,BIOCTR,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND
关键词
D O I
10.1038/clpt.1990.4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the oxidation capacity in liver biopsies of a series of extensive metabolizers (n = 10) and poor metabolizers (n = 2) as identified by in vivo phenotyping with dextromethorphan. Codeine and dextromethorphan were used as probe drugs in vitro. The data were compared with the contents of cytochrome P-450IID1 as quantitated by Western immunoblotting by use of a specific monoclonal antibody (MAb 114 2). The O-demethylation of codeine was highly correlated with the O-demethylation of dextromethorphan (r = 0.90). The N-demethylation of codeine was catalyzed at a considerably higher rate than the O-demethylation. The N-demethylation to O-demethylation ratio of codeine was 46 in the poor metabolizer and, on average, 6.2 (range, 2.6 to 11) in the extensive metabolizers, respectively. The band intensity in Western blots correlated with the rate of O-demethylation of codeine (r = 0.95) and of dextromethorphan (r = 0.88) in the extensive metabolizers. The comeasurement of the O-demethylation and N-demethylation of codeine may provide a tool with which to phenotype individuals in vitro with respect to the polymorphism of the cytochrome P-450IID1. © 1990.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 21 条
[1]   ENZYMATIC BASIS OF THE DEBRISOQUINE SPARTEINE-TYPE GENETIC-POLYMORPHISM OF DRUG OXIDATION - CHARACTERIZATION OF BUFURALOL 1'-HYDROXYLATION IN LIVER-MICROSOMES OF INVIVO PHENOTYPED CARRIERS OF THE GENETIC DEFICIENCY [J].
DAYER, P ;
KRONBACH, T ;
EICHELBAUM, M ;
MEYER, UA .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (23) :4145-4152
[2]   BIOACTIVATION OF THE NARCOTIC DRUG CODEINE IN HUMAN-LIVER IS MEDIATED BY THE POLYMORPHIC MONOOXYGENASE CATALYZING DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P-450 DBL/BUFI) [J].
DAYER, P ;
DESMEULES, J ;
LEEMANN, T ;
STRIBERNI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :411-416
[3]   DETERMINATION OF DEXTROMETHORPHAN AND METABOLITES IN HUMAN-PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
EAST, T ;
DYE, D .
JOURNAL OF CHROMATOGRAPHY, 1985, 338 (01) :99-112
[4]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[5]   CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].
GONZALEZ, FJ ;
SKODA, RC ;
KIMURA, S ;
UMENO, M ;
ZANGER, UM ;
NEBERT, DW ;
GELBOIN, HV ;
HARDWICK, JP ;
MEYER, UA .
NATURE, 1988, 331 (6155) :442-446
[6]   POLYMORPHISMS OF OXIDATION AT CARBON CENTERS OF DRUGS AND THEIR CLINICAL SIGNIFICANCE [J].
IDLE, JR ;
SMITH, RL .
DRUG METABOLISM REVIEWS, 1979, 9 (02) :301-317
[7]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAYS FOR BUFURALOL 1'-HYDROXYLASE, DEBRISOQUINE 4-HYDROXYLASE, AND DEXTROMETHORPHAN O-DEMETHYLASE IN MICROSOMES AND PURIFIED CYTOCHROME-P-450 ISOZYMES OF HUMAN-LIVER [J].
KRONBACH, T ;
MATHYS, D ;
GUT, J ;
CATIN, T ;
MEYER, UA .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :24-32
[8]  
KUPFER A, 1984, LANCET, V2, P157
[9]   MONOCLONAL-ANTIBODY DIRECTED DETECTION OF CYTOCHROME-P-450 (PCN) IN HUMAN-FETAL LIVER [J].
LADONA, MG ;
PARK, SS ;
GELBOIN, HV ;
HAMMAR, L ;
RANE, A .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) :4735-4741
[10]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+